Istituto Oncologico Veneto Irccs
Clinical trials sponsored by Istituto Oncologico Veneto Irccs, explained in plain language.
-
Cancer pill shows promise against tough brain tumor
Disease control Recruiting nowThis phase 2 trial tests whether the drug regorafenib can slow tumor growth in people with recurrent meningioma, a type of brain tumor. About 104 participants will receive either regorafenib or standard care. The main goal is to see how long the tumor stays under control.
Phase: PHASE2 • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Electric shocks + chemo: new hope for inoperable tumors?
Disease control Recruiting nowThis study tests a treatment called electrochemotherapy for people with tumors in organs like the liver or pancreas that cannot be removed by surgery. The treatment uses short electrical pulses to help chemotherapy drugs enter cancer cells more effectively. The goal is to shrink …
Phase: NA • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could a milk thistle extract help fight brain cancer?
Disease control Recruiting nowThis study tests whether adding silibinin (a milk thistle extract) to standard chemoradiation and maintenance chemotherapy can delay tumor growth in people with a specific type of newly diagnosed glioblastoma. About 110 adults whose tumors have a certain protein marker (STAT3-pos…
Phase: NA • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New wound dressing aims to cut surgery complications in sarcoma patients
Disease control Recruiting nowThis study tests if a single-use negative pressure wound dressing (PICO14) can reduce wound problems after surgery for limb sarcoma in patients who had radiation therapy. About 48 adults will be randomly assigned to get either the special dressing or standard gauze. The main goal…
Phase: NA • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New device aims to calm bladder irritation during cancer therapy
Symptom relief Recruiting nowThis study tests whether adding Hydeal Cyst® instillations can reduce lower urinary tract symptoms in people receiving standard chemotherapy or immunotherapy for non-muscle invasive bladder cancer. About 200 participants will receive either BCG or MMC, and half will also get Hyde…
Phase: NA • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Virtual reality headsets tested to ease pain and fear in urology patients
Symptom relief Recruiting nowThis study tests whether using a virtual reality headset (REALICA) can lower pain and anxiety in people undergoing common urology procedures like prostate biopsy, cystoscopy, or circumcision. About 56 adults having these procedures for the first time will use the VR device during…
Phase: NA • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Scientists investigate rare breast cancer subtype to improve future care
Knowledge-focused Recruiting nowThis study looks back at medical records of 250 people with a rare type of breast cancer called apocrine lobular carcinoma. Researchers want to understand how this cancer behaves, what treatments patients received, and how they did over time. No new treatments are tested — the go…
Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New breast surgery technique aims to reduce scars and improve outcomes
Knowledge-focused Recruiting nowThis study reviews data from 250 women who had a special type of breast-conserving surgery for early-stage breast cancer. The surgery uses nearby skin and fat flaps to fill the area where the tumor was removed, aiming to avoid visible scars and keep the breast looking natural. Re…
Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Scientists target Cancer's weak spot: redox imbalance
Knowledge-focused Recruiting nowThis study looks for new ways to kill T-cell leukemia and lymphoma cells by disrupting their internal balance of reactive oxygen species. Researchers will test drug combinations in lab-grown cells and in samples from 120 patients with resistant disease. The goal is to find treatm…
Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
Scientists dive deep into mesothelioma tumors to unlock new treatment clues
Knowledge-focused Recruiting nowThis study is looking at tumor samples from 220 people with pleural or peritoneal mesothelioma, a rare cancer linked to asbestos. Researchers will analyze the genes and immune cells in these tumors to find patterns that could predict which treatments work best. The goal is to imp…
Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:08 UTC